Why is Novartis India Ltd ?
1
The company is Net-Debt Free
2
Healthy long term growth as Operating profit has grown by an annual rate 40.23%
3
The company has declared positive results in Jun'2026 after 2 consecutive negative quarters
- CASH AND CASH EQUIVALENTS(HY) Highest at Rs 667.70 cr
- DEBTORS TURNOVER RATIO(HY) Highest at 9.56 times
- NET SALES(Q) Highest at Rs 103.81 cr
4
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 0.81% over the previous quarter and collectively hold 1.52% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
How much should you buy?
- Overall Portfolio exposure to Novartis India should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
-0.86%
EBIT Growth (5y)
40.23%
EBIT to Interest (avg)
54.25
Debt to EBITDA (avg)
0.42
Net Debt to Equity (avg)
-0.81
Sales to Capital Employed (avg)
0.48
Tax Ratio
27.90%
Dividend Payout Ratio
61.15%
Pledged Shares
0
Institutional Holding
1.52%
ROCE (avg)
36.34%
ROE (avg)
11.13%
Valuation Key Factors 
Factor
Value
P/E Ratio
40
Industry P/E
37
Price to Book Value
4.83
EV to EBIT
32.86
EV to EBITDA
32.26
EV to Capital Employed
21.41
EV to Sales
8.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
60.10%
ROE (Latest)
11.95%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Movement
9What is working for the Company
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 667.70 cr
DEBTORS TURNOVER RATIO(HY)
Highest at 9.56 times
NET SALES(Q)
Highest at Rs 103.81 cr
PBDIT(Q)
Highest at Rs 34.91 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 33.63%
PBT LESS OI(Q)
At Rs 34.43 cr has Grown at 29.39%
PAT(Q)
Highest at Rs 32.21 cr.
EPS(Q)
Highest at Rs 13.05
-3What is not working for the Company
ROCE(HY)
Lowest at 15.95%
Loading Valuation Snapshot...
Here's what is working for Novartis India
Net Sales - Quarterly
Highest at Rs 103.81 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 34.91 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 33.63%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 34.43 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 34.43 cr has Grown at 29.39%
Year on Year (YoY)MOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 32.21 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 13.05
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 667.70 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debtors Turnover Ratio- Half Yearly
Highest at 9.56 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio






